Chris Hirst

Chris Hirst is the Chief Executive Officer at Bespak. They have held a series of leadership and business-development roles at Recipharm and its affiliates, including Head of Business Unit: Advanced Delivery Systems (2022–2024) and General Manager of RPH Pharmaceuticals AB (Recipharm AB) (2018–2021), as well as Head of RPH Pharmaceuticals AB (2018) and Head of Business Development (2017–2018). Earlier, they served as Business Development Manager at Recipharm AB (2014–2017) and held roles such as Commercial Supply Manager and Account Manager. Prior to that, they worked as Laboratory Analyst at AstraZeneca (1997–2003) and at GSK Consumer Health (AUS) (2004–2005), and held project-management and stability roles at Recipharm Ltd (2005–2006) and as an R&D Project Manager at Lantor UK Ltd (2008–2009). They attended The Manchester Metropolitan University from 2006 to 2009.